Cision PR Newswire

AI Memory & Storage: The 5th GMIF2026 Innovation Summit Successfully Concludes in Shenzhen

SHENZHEN, China, Sept. 26, 2026 /PRNewswire/ -- On September 23, the 5th GMIF2026 Innovation Summit successfully concluded at the Renaissance Shenzhen Bay Hotel. Co-hosted by the Shenzhen Memory Industry Association (SMIA) and School of Integrated Circuits at Peking University, the summit, themed "The Future Built on AI Memory and...

2026 Beijing International Week for Science Literacy Launched in Beijing

BEIJING, Sept. 27, 2026 /PRNewswire/ -- The 2026 Beijing International Week for Science Literacy...

2026 IMS | IASO Bio Presented FUCASO China Real-World Data

--- In a large China real-world study of 281 heavily pretreated, predominantly high-risk patients...

2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206

— Late-breaking oral presentation of first-in-human data (LBA-11) showed that a single intravenous infusion...

SEGI FRESH UNVEILS NEW STORE CONCEPT AND REFRESHED BRAND IDENTITY IN BIDOR

BIDOR, Malaysia, Sept. 26, 2026 /PRNewswire/ -- Segi Fresh, Malaysia's Top 1 Fresh Mart,...

MANTRA Secures First VARA DeFi License, Paving the Way for Global Growth and Innovation in Financial Products

DUBAI, UAE, Feb. 19, 2025 /PRNewswire/ -- MANTRA Finance FZE (MANTRA), a leading decentralized finance (DeFi) platform operated by MANTRA Group, today announces it has...

BGM Group Establishes “Duxiaobao Management Committee” to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry

CHENGDU, China, Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the...

Ascletis Announces Positive Interim Results from First Two Cohorts of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30

-  ASC30 oral once-daily tablet demonstrated a 6.3% mean body weight reduction from baseline after 28-day treatment in multiple ascending dose (MAD) cohort 2 (weekly...

BluMaiden Biosciences Appoints New US-based Leadership to Accelerate Global Expansion

-       Dr. Terence Kelly named interim CEO and Prof. Damian O'Connell named Chair of the Scientific Advisory Board, joins Board of Directors-       Appointment of...